CBD OIL FOR BRAIN- NOOTROPICS

CBD OIL FOR BRAIN- NOOTROPICS

So as most of you probably know, a compound found in cannabis called Cannabidiol(CBD), has been receiving a lot of attention over the last couple years. The health claims for this substance are definitely interesting to me. It must first be noted that CBD is NOT psychoactive and does not get you high, so if you do not enjoy the mental effects of marijuana don’t worry. The reported benefits of CBD include Anti-Psychotic properties, Anxiolytic, and Pain management. Some USA Oils that are sold have ZERO THC From distributors like Folium Biosciences and Entourage Nutritional. 

CBD OIL FOR BRAIN- NOOTROPICS

In short, these are substances that enhance cognitive performance in some way. Some are natural, in the form of herbs or high-dose vitamins, while others are man-made and pharmaceutical. Technically, while “smart drugs” typically refer to any pharmaceutical (or nutritional substance) that increase brain performance, nootropics must fulfill five criteria defined by the man who coined the term, Dr. Corneliu E. Giurgea:

  1. The substance should enhance the brain in some way.
  2. It should improve cognitive performance under stress (such as electrical shock or oxygen deprivation)
  3. The substance should have protective properties that protect the brain against harmful substances.
  4. The substance should “increase the efficacy of neuronal firing control mechanisms in cortical and sub-cortical regions of the brain.” (1)
  5. It should be non-toxic and have no harmful side effects.

CBD OIL FOR BRAIN- NOOTROPICS

Resource Links:

1- Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines

2- Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival

3- Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas

4- Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism

5- Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target

6- Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme

7- Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect

8- Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents

 *These statements have not been evaluated by the Food and Drug Administration.  This product is not intended to diagnose, treat, cure or prevent any disease.